Difficulty: Medium
Average Score: 84%
Practice
One of the following medications used in treatment of atopic dermatitis should be discontinued after failure to achieve good results within 4-6 weeks
Correct answer
C
Rationale
In the treatment of atopic dermatitis, it is crucial to monitor the response to medications to ensure optimal outcomes for pediatric patients. Omalizumab, as the correct answer, is a monoclonal antibody that targets immunoglobulin E (IgE) and is typically used for severe cases of atopic dermatitis. If a pediatric patient fails to show improvement within 4-6 weeks of starting omalizumab, it should be discontinued as it may indicate inefficacy or the need to explore alternative treatment options.
Regarding the incorrect options:
- A) Methotrexate is a medication used in severe cases of atopic dermatitis, but discontinuation is not solely based on a lack of response within a specific timeframe.
- B) Azathioprine is an immunosuppressant that may take longer to show results, and discontinuation should be guided by the healthcare provider's assessment of the patient's response.
- D) Mycophenolate mofetil is another immunosuppressant that may require a longer duration to evaluate its effectiveness in managing atopic dermatitis.
In an educational context, understanding the rationale behind discontinuing medications in the treatment of atopic dermatitis is essential for pediatric nurses to provide safe and effective care. Monitoring the response to treatment, knowing when to discontinue a medication, and collaborating with the healthcare team for alternative options are critical aspects of pediatric nursing practice. This knowledge ensures that pediatric patients receive appropriate and timely interventions to manage their atopic dermatitis effectively.
Regarding the incorrect options:
- A) Methotrexate is a medication used in severe cases of atopic dermatitis, but discontinuation is not solely based on a lack of response within a specific timeframe.
- B) Azathioprine is an immunosuppressant that may take longer to show results, and discontinuation should be guided by the healthcare provider's assessment of the patient's response.
- D) Mycophenolate mofetil is another immunosuppressant that may require a longer duration to evaluate its effectiveness in managing atopic dermatitis.
In an educational context, understanding the rationale behind discontinuing medications in the treatment of atopic dermatitis is essential for pediatric nurses to provide safe and effective care. Monitoring the response to treatment, knowing when to discontinue a medication, and collaborating with the healthcare team for alternative options are critical aspects of pediatric nursing practice. This knowledge ensures that pediatric patients receive appropriate and timely interventions to manage their atopic dermatitis effectively.